Bo Hyun Kim

7PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 07, 2026
Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study.

Yuri Cho, Jeong-Hoon Lee, Baek-Yeol Ryoo

|Apr 02, 2024
Prevalence, Incidence, and Treatment Pattern of Wilson's Disease Using National Health Insurance Data From 2010-2020, Korea.

Eun Sun Jang, Hwa Young Choi, Moran Ki

|Jun 29, 2023
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment.

Yuri Cho, Bo Hyun Kim, Tae Hyun Kim

|Jun 29, 2023
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria.

Yuri Cho, Bo Hyun Kim, Tae Hyun Kim

|Jun 29, 2023
Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment.

Bo Hyun Kim, Joong-Won Park

|Nov 16, 2020
Selecting the Right Tool for the Right Job: Which Response Criteria Better Predicts Survival of Patients Treated with Transarterial Radioembolization?

Bo Hyun Kim

Pageof 2

Frequent Collaborators

5 joint publications

Joong-Won Park

3 joint publications

Yuri Cho

2 joint publications

Tae Hyun Kim

2 joint publications

Young Hwan Koh